Motion Stimulation Therapy Market Report 2026

Motion Stimulation Therapy Market Overview

• Motion Stimulation Therapy market size has reached to $1.96 billion in 2025 • Expected to grow to $2.89 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: Increasing Incidence Of Musculoskeletal Disorders Fueling The Growth Of The Market Due To Aging Population And Rising Prevalence Of Chronic Conditions • Market Trend: Innovative Closed-Loop Spinal Cord Stimulator Enhances Real-Time Pain Relief • North America was the largest region in 2025.

What Is Covered Under Motion Stimulation Therapy Market?

Motion stimulation therapy is a therapeutic technique that uses controlled movements or mechanical motion to stimulate the body or specific tissues. Its primary purpose is to enhance circulation, reduce muscle stiffness, and promote healing by encouraging natural motion and sensory feedback. This therapy is often used in rehabilitation to improve mobility and alleviate pain. The main therapy types of motion stimulation therapy are functional neuromuscular motion stimulation therapy, peripheral motion stimulation therapy, deep brain motion stimulation therapy, and therapeutic electrical motion stimulation therapy. Functional neuromuscular motion stimulation therapy refers to a therapeutic approach that uses electrical stimulation to activate muscles and nerves, enhancing muscle function and improving motor control. This therapy is applied in various fields such as diabetes management, pain management, oncology, cardiovascular diseases, infectious diseases, and others, serving end users such as hospitals, specialty clinics, and others.

What Is The Motion Stimulation Therapy Market Growth Forecast?

The motion stimulation therapy market size is expected to see strong growth in the next few years. It will grow to $2.89 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing demand for personalized rehabilitation treatments, rising adoption of remote and home-based therapy solutions, expansion of neurological disorder treatment programs, growing integration of ai-driven therapy optimization, increasing healthcare investments in rehabilitation technologies. Major trends in the forecast period include increasing adoption of robotic-assisted motion therapy devices, rising integration of sensor-based motion feedback systems, growing use of personalized rehabilitation protocols, expansion of home-based motion therapy solutions, enhanced focus on neuromuscular recovery outcomes.

Global Motion Stimulation Therapy Market Segmentation

1) By Therapy Type: Functional Neuromuscular Motion Stimulation Therapy, Peripheral Motion Stimulation Therapy, Deep Brain Motion Stimulation Therapy, Therapeutic Electrical Motion Stimulation Therapy 2) By Applications: Neurological Rehabilitation, Pain Management, Musculoskeletal Rehabilitation, Cardiovascular Diseases, Post-Surgical Rehabilitation, Others Applications 3) By End User: Hospitals, Specialty Clinics, Other End Users Subsegments: 1) By Functional Neuromuscular Motion Stimulation Therapy: Muscle Activation, Nerve Stimulation, Reflex Enhancement 2) By Peripheral Motion Stimulation Therapy: Limb Motion Stimulation, Joint Motion Stimulation, Soft Tissue Motion Stimulation 3) By Deep Brain Motion Stimulation Therapy: Subthalamic Nucleus Stimulation, Globus Pallidus Stimulation, Thalamic Stimulation 4) By Therapeutic Electrical Motion Stimulation Therapy: Transcutaneous Electrical Nerve Stimulation, Functional Electrical Stimulation, Neuromuscular Electrical Stimulation

What Is The Driver Of The Motion Stimulation Therapy Market?

The increasing incidence of musculoskeletal disorders is expected to propel the growth of the motion stimulation therapy market going forward. Musculoskeletal disorders refer to conditions affecting muscles, bones, joints, tendons, and ligaments that cause pain or impair movement. The rise in prevalence of musculoskeletal disorders is due to the aging global population, as people naturally experience joint degeneration and reduced bone density over time. Motion stimulation therapy enhances musculoskeletal disorder treatment by promoting improved mobility and reducing pain. It offers targeted stimulation to affected areas, supporting faster recovery and better patient outcomes. For instance, in January 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, the prevalence of long-term musculoskeletal (MSK) conditions in people aged 16 and over who self-reported was 18.4% in 2023, an increase from 17.6% in 2022. Therefore, the increasing incidence of musculoskeletal disorders is driving the growth of the motion stimulation therapy industry.

Key Players In The Global Motion Stimulation Therapy Market

Major companies operating in the motion stimulation therapy market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Ottobock SE & Co. KGaA, Nevro Corporation, Zynex Medical Inc., BTL Industries Inc., Onward Medical Inc., Enraf-Nonius B.V., Hocoma AG, Tyromotion GmbH, Ekso Bionics Holdings Inc., Mettler Electronics Corporation, Bioness Inc., Restorative Therapies Inc., ARPwave Therapy, Innovative Neurotronics Inc., St. Jude Medical Inc., Technomed Electronics Co Ltd., LivaNova PLC, NeuroMetrix Inc., EMS Physio Ltd., Chattanooga Group

Global Motion Stimulation Therapy Market Trends and Insights

Major companies operating in the motion stimulation therapy market are focusing on developing innovative solutions, such as closed-loop spinal cord stimulators, to enhance real-time pain management and improve patient outcomes. Closed-loop spinal cord stimulators are advanced devices that continuously monitor nerve signals and automatically adjust stimulation levels to provide personalized and effective pain relief. For instance, in April 2024, Medtronic plc, an Ireland-based medical technology company, received approval from the U.S. Food and Drug Administration (FDA) for the Inceptiv closed-loop rechargeable spinal cord stimulator for the treatment of chronic pain. This innovative device is designed to improve motion stimulation therapy by dynamically adjusting to patients' movements and pain levels. It monitors nerve signals 50 times per second and automatically modifies stimulation in real time to provide consistent, personalized pain relief throughout daily activities. Additionally, it is the smallest and thinnest spinal cord stimulator available, offering full-body MRI compatibility at both 1.5T and 3T, ensuring greater patient comfort and uninterrupted access to diagnostic imaging.

What Are Latest Mergers And Acquisitions In The Motion Stimulation Therapy Market?

In February 2023, Confluent Health LLC, a US-based healthcare company, acquired Motion PT Group for an undisclosed amount. With this acquisition, Confluent Health aims to expand its national footprint and enhance patient care through increased access to advanced management services and innovative musculoskeletal health programs. Motion PT Group is a US-based company that specializes in motion stimulation therapy.

Regional Outlook

North America was the largest region in the motion simulation therapy market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Motion Stimulation Therapy Market?

The motion stimulation therapy market consists of revenues earned by entities by providing services such as soft tissue motion therapy, limb motion stimulation, subthalamic nucleus stimulation, and pain management stimulation. The market value includes the value of related goods sold by the service provider or included within the service offering. The motion stimulation therapy market also includes sales of spinal cord stimulators, wearable motion therapy devices, vagus nerve stimulators, and implantable pulse generators. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Motion Stimulation Therapy Market Report 2026?

The motion stimulation therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the motion stimulation therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.